> Anything short of a successful human trial is ... nothing. RECOVERY just posted their preliminary results on dexamethasone. The NIAID trials showed efficacy

> Anything short of a successful human trial is ... nothing. RECOVERY just posted their preliminary results on dexamethasone. The NIAID trials showed efficacy of remedisivir. But getting a trial right can take some time. RECOVERY started in March, and had to enroll 10,000 patients or so. A lot of trials are running at this point, it is a matter of collecting data and drawing conclusions. Antibody based therapies are probably the ones going to be the most effective, but I worry about the cost (they aren't cheap). > The false hope of a vaccine or cure has caused some US governors to announce waiting for a vaccine before ending lockdown. That is misguided as much as saying that there is no cure (yet). In fact, I'd say that most governments focused too much on vaccines and too little on pharmacological interventions. FTR, for SARS, a lot of programs were halted because it fizzled out, and so it was impossible to actually test them. For MERS though, there were vaccines in development (and still are), and that's why most of the stakeholders were this fast in getting candidates ready.